This issue, edited by Dr. Rakesh Kumar, reviews current clinical information in "PET Based Interventions." Articles will include: PET/CT in Radiofrequency Ablation; PET/CT Guided FNAC/Biopsy; PET/CT in Radiotherapy Planning; Dual Time Point Imaging; The Role of PET in Radiation Oncology; PET/CT in Individualization of Treatment (Personalized medicine); Ga68-DOTA-TOC PET/CT in targeted radionuclide therapy (Lu188 therapy for NET); Role of FDG PET/CT in Targeted Radionuclide Therapy of Endocrine Malignancies; Overview of Conventional Imaging Based Intervention in Clinical Practice; Special Techniques in PET/CT in Evaluating Genito-urinary Malignancies; and more!
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 7 7. CME Accreditation Page - p. 8 8. Preface: PET/Computed Tomography-based Intervention - p. 9 9. Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies - p. 10 10. Application and Dosimetric Requirements for Gallium-68–labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors - p. 20 11. PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer - p. 27 12. PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy - p. 33 13. PET/Computed Tomography in Evaluation of Transarterial Chemoembolization - p. 41 14. PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy) - p. 49 15. Utility of PET for Radiotherapy Treatment Planning - p. 61 16. Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy–related Complications - p. 71
This issue, edited by Dr. Rakesh Kumar, reviews current clinical information in "PET Based Interventions." Articles will include: PET/CT in Radiofrequency Ablation; PET/CT Guided FNAC/Biopsy; PET/CT in Radiotherapy Planning; Dual Time Point Imaging; The Role of PET in Radiation Oncology; PET/CT in Individualization of Treatment (Personalized medicine); Ga68-DOTA-TOC PET/CT in targeted radionuclide therapy (Lu188 therapy for NET); Role of FDG PET/CT in Targeted Radionuclide Therapy of Endocrine Malignancies; Overview of Conventional Imaging Based Intervention in Clinical Practice; Special Techniques in PET/CT in Evaluating Genito-urinary Malignancies; and more!
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 7 7. CME Accreditation Page - p. 8 8. Preface: PET/Computed Tomography-based Intervention - p. 9 9. Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies - p. 10 10. Application and Dosimetric Requirements for Gallium-68–labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors - p. 20 11. PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer - p. 27 12. PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy - p. 33 13. PET/Computed Tomography in Evaluation of Transarterial Chemoembolization - p. 41 14. PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy) - p. 49 15. Utility of PET for Radiotherapy Treatment Planning - p. 61 16. Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy–related Complications - p. 71
